Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2020.00271
Full Text
Open PDFAbstract
Available in full text
Date
March 3, 2020
Authors
Publisher
Frontiers Media SA